Skip to content

Post-Market Data Collection to Evaluate the Performance of the Synergy Disc®

A Single Site Post-Market Data Collection Protocol to Evaluate the Performance of Synergy Spine Solutions Synergy Disc®

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06383962
Enrollment
50
Registered
2024-04-25
Start date
2025-03-17
Completion date
2034-12-01
Last updated
2026-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Degenerative Disc Disease

Brief summary

This is a real world data collection observational study at a single site. There are both prospective and retrospective cohorts. The study will examine the safety and effectiveness of the Synergy cervical disc system in patients with degenerative cervical disc disease.

Interventions

DEVICESynergy cervical spine disc replacement

motion preservation disc

Sponsors

Synergy Spine Solutions
Lead SponsorINDUSTRY
MCRA
CollaboratorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum

Inclusion criteria

Age 21 or above at the time of the surgery. Have had (retrospective cohort) or the decision has been made to have (prospective cohort) the Synergy Disc implanted Skeletally mature patients for reconstruction of the disc from C3-C7 following a single or multiple level discectomy for intractable radiculopathy Intractable radiculopathy and/or myelopathy with at least one of the following producing symptomatic nerve root and/or spinal cord compression: herniated disc and/or osteophyte formation Symptomatic nerve root and/or spinal cord compression documented by patient history (arm or neck pain and/or neurologic deficit) and imaging (CT, MRI, x-rays, etc.) Failed a minimum of 6 weeks conservative treatment Written informed consent given by subject.

Design outcomes

Primary

MeasureTime frameDescription
Neck Disability Index (NDI)12 monthsNeck disability Index improvement of \>15 pts (out of 100) in subjects by 12 months post operative compared with baseline. A lower score is a better score.
Device Related or Device Procedure Related Adverse Events12 monthsAbsence of major device related adverse events defined as radiographic failure, neurologic failure or failure by adverse event

Secondary

MeasureTime frameDescription
Neck and Arm Pain Measurementpre-operative, 6 week, 3 month, 6 month, 12 month, 24 monthPain will evaluated by the Visual analog scale (VAS) (place a line from zero where there is no pain to 10 which is the worst pain imaginable), by NRS (circle a number from zero to ten where zero equals no pain and ten is worst imaginable) to or a verbal description that the doctor writes down, per the site's Standard of Care. A change of at least 20 mm will be considered clinically significant. Neck pain as measured on a 100mm VAS at baseline and at each follow-up timepoint. Left and Right arm/shoulder pain as measured on a 100 mm VAS at baseline and at each follow up time-point.
Patient Satisfaction6 week, 3 month, 6 month, 12 month, 24 monthpatient completed questionnaire on their satisfaction with the disc replacement surgery
Motor and Sensory Function in the Armpre-operative, 6 week, 3 month, 6 month, 12 month, 24 monthmaintenance or improvement in neurologic status compared with baseline will be assessed using a defined numeric scale ranging from 0 (normal) to 5 (deficit)
Nurick's Criteriapre-operative, 6 week, 3 month, 6 month, 12 month, 24 monthDisease status as characterized by physician at each time point
Odom's criteriapre-operative, 6 week, 3 month, 6 month, 12 month, 24 monthsurgical outcome characterized by physician at each post operative visit

Countries

United Kingdom

Contacts

CONTACTRobyn Capobianco, PhD
rcapobianco@synergyspinesolutions.com(720) 787-9063
STUDY_DIRECTORRobyn Capobianco, PhD

Synergy Spine Solutions

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 2, 2026